LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Relative Growth Rate Standard Error of the Mean for Relative Growth Rate
SK-BR-3 WZ-4-145
10.0
uM
LJP6
0.2553 0.0336 -0.2450 0.1176
SK-BR-3 XMD16-144
10.0
uM
LJP5
0.2745 0.0122 -0.2108 0.0864
SK-BR-3 Brivanib
10.0
uM
LJP5
0.9030 0.0320 0.8350 0.0558
SK-BR-3 Buparlisib
10.0
uM
LJP5
0.2276 0.0042 -0.2883 0.0825
SK-BR-3 BX-912
10.0
uM
LJP5
0.3797 0.0255 -0.0310 0.0496
SK-BR-3 Canertinib
10.0
uM
LJP6
0.2673 0.0042 -0.2207 0.0671
SK-BR-3 Celastrol
10.0
uM
LJP6
0.2848 0.0159 -0.1893 0.0474
SK-BR-3 CGP60474
10.0
uM
LJP5
0.2228 0.0188 -0.2992 0.1081
SK-BR-3 CGP60474
10.0
uM
LJP6
0.1653 0.0190 -0.3933 0.1036
SK-BR-3 CHIR-99021
10.0
uM
LJP6
0.6624 0.0499 0.4290 0.1084
SK-BR-3 CP724714
10.0
uM
LJP5
0.3507 0.0112 -0.0801 0.0453
SK-BR-3 CP466722
10.0
uM
LJP5
0.6702 0.1754 0.4811 0.2785
SK-BR-3 Crizotinib
10.0
uM
LJP5
0.3028 0.0079 -0.1607 0.0566
SK-BR-3 Momelotinib
10.0
uM
LJP5
0.4329 0.0336 0.0610 0.0188
SK-BR-3 Dasatinib
10.0
uM
LJP5
0.4018 0.0370 0.0049 0.0710
SK-BR-3 Dasatinib
10.0
uM
LJP6
0.2314 0.0092 -0.2795 0.0621
SK-BR-3 Dovitinib
10.0
uM
LJP5
0.4756 0.0224 0.1301 0.0188
SK-BR-3 Enzastaurin
10.0
uM
LJP5
0.9905 0.0686 0.9905 0.1195
SK-BR-3 Erlotinib
10.0
uM
LJP5
0.4894 0.0073 0.1483 0.0571
SK-BR-3 Foretinib
10.0
uM
LJP5
0.3449 0.0158 -0.0908 0.0613
SK-BR-3 R406
10.0
uM
LJP6
0.7507 0.0193 0.5882 0.0085
SK-BR-3 Pictilisib
10.0
uM
LJP6
0.3569 0.0275 -0.0745 0.0966
SK-BR-3 Gefitinib
10.0
uM
LJP6
0.4241 0.0162 0.0389 0.0730
SK-BR-3 Geldanamycin
10.0
uM
LJP5
0.1761 0.0205 -0.3771 0.1129
SK-BR-3 Geldanamycin
10.0
uM
LJP6
0.1901 0.0054 -0.3491 0.0711